查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1886299

透皮贴片市场－全球产业规模、份额、趋势、机会和预测，按贴片类型、黏合剂类型、应用、最终用户、地区和竞争格局划分，2020-2030年预测

Transdermal Patches Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Patch Type, By Adhesive Type, By Application, By End-User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024年全球透皮贴片市场规模为68.5亿美元，预计2030年将以5.03%的复合年增长率成长至92亿美元。透皮贴片是一种药物黏附系统，旨在透过皮肤进行全身给药，绕过肝臟首过代谢，提供非侵入性且稳定的治疗剂量。市场成长的主要驱动因素是全球慢性病盛行率的不断上升，这些疾病需要长期用药管理，以及患者明显倾向于选择便捷、非侵入性的给药方式，而非传统的口服或註射途径。

市场概览
预测期 2026-2030
市场规模：2024年 68.5亿美元
市场规模：2030年 92亿美元
复合年增长率：2025-2030年 5.03%
成长最快的细分市场 医院和诊所
最大的市场 北美洲

主要市场驱动因素

全球慢性疾病负担日益加重，成为推动透皮贴片市场发展的关键因素，尤其对于需要持续、长期用药的疾病更是如此。透皮贴片系统具有显着优势，能够实现药物的持续释放，与传统的口服或註射给药途径相比，可提高患者的依从性和治疗的稳定性。

主要市场挑战

皮肤渗透性的固有限制严重阻碍了全球透皮贴片市场的成长。这种生理屏障从根本上限制了可透过皮肤途径有效递送的活性药物成分的分子大小和理化性质。

主要市场趋势

微针技术的进步从根本上拓展了透皮给药的途径，它能够突破皮肤屏障，从而实现更广泛的治疗药物（包括大分子药物）的给药。这些贴片在角质层中形成微小通道，以最小的侵入性和更少的不适感实现药物的高效渗透，从而拓宽了透皮给药的应用范围。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球透皮贴片市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依贴片类型（药物黏合剂贴片、基质贴片、储库膜贴片、微针贴片、蒸气贴片）
    • 依黏合剂类型（丙烯酸、硅胶、水凝胶、其他）
    • 依应用领域（疼痛管理、荷尔蒙应用、中枢神经系统疾病、心血管疾病、戒烟、其他）
    • 按最终使用者（家庭护理机构、医院和诊所）
    • 按地区
    • 按公司（2024 年）
  • 市场地图

第六章：北美透皮贴片市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章：欧洲透皮贴片市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区透皮贴片市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲透皮贴片市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非

第十章：南美透皮贴片市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章：市场动态

  • 司机
  • 挑战

第十二章：市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章：全球透皮贴片市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商议价能力
  • 顾客的力量
  • 替代产品的威胁

第十五章：竞争格局

  • AbbVie, Inc.
  • AdhexPharma SAS
  • Agile Therapeutics, Inc.
  • Boehringer Ingelheim International GmbH
  • Corium, Inc.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Hamamatsu Pharma Research, Inc.
  • Endo, Inc.

第十六章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 23930

The Global Transdermal Patches Market, valued at USD 6.85 Billion in 2024, is projected to experience a CAGR of 5.03% to reach USD 9.20 Billion by 2030. Transdermal patches represent medicated adhesive systems designed for systemic drug delivery through the skin, offering a non-invasive and consistent therapeutic dosage by bypassing hepatic first-pass metabolism. The market's growth is principally driven by the increasing global prevalence of chronic diseases requiring long-term medication management and a discernible patient preference for convenient, non-invasive drug administration over traditional oral or injectable routes.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 6.85 Billion
Market Size 2030USD 9.20 Billion
CAGR 2025-20305.03%
Fastest Growing SegmentHospitals & Clinics
Largest MarketNorth America

Key Market Drivers

The escalating global burden of chronic diseases stands as a pivotal driver for the transdermal patches market, particularly for conditions necessitating continuous and often long-term medication management. Transdermal systems offer distinct advantages by enabling sustained drug release, which enhances patient adherence and therapeutic consistency over conventional oral or injectable routes. This non-invasive administration lessens the discomfort associated with frequent dosing and potential systemic side effects, improving the quality of life for individuals with persistent health issues.

Key Market Challenges

The inherent limitation of skin permeability poses a significant impediment to the growth of the Global Transdermal Patches Market. This physiological barrier fundamentally restricts the molecular size and physicochemical properties of active pharmaceutical ingredients that can be effectively delivered through the dermal route. Consequently, the range of drug candidates suitable for transdermal formulation is substantially narrowed, limiting the expansion of transdermal patches into numerous therapeutic areas. Large molecule biologics, for example, which represent a growing segment of pharmaceutical innovation, are generally incompatible with transdermal delivery due to their size.

Key Market Trends

Advancements in microneedle technology are fundamentally expanding transdermal drug delivery by overcoming the skin's barrier, enabling the administration of a wider range of therapeutic agents, including larger molecules. These patches create microscopic channels in the stratum corneum for efficient drug permeation with minimal invasiveness and reduced discomfort, broadening transdermal applications.

Key Market Players

  • AbbVie, Inc.
  • AdhexPharma SAS
  • Agile Therapeutics, Inc.
  • Boehringer Ingelheim International GmbH
  • Corium, Inc.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Hamamatsu Pharma Research, Inc.
  • Endo, Inc.

Report Scope:

In this report, the Global Transdermal Patches Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Transdermal Patches Market, By Patch Type:

  • Drug-In-Adhesive
  • Matrix Patches
  • Reservoir Membrane Patches
  • Microneedle Patches
  • Vapour Patches

Transdermal Patches Market, By Adhesive Type:

  • Acrylic
  • Silicone
  • Hydrogel
  • Other

Transdermal Patches Market, By Application:

  • Pain Management
  • Hormonal Application
  • Central Nervous System Disorders
  • Cardiovascular Diseases
  • Smoking Cessation
  • Other

Transdermal Patches Market, By End-User:

  • Homecare Settings
  • Hospitals & Clinics

Transdermal Patches Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Transdermal Patches Market.

Available Customizations:

Global Transdermal Patches Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Transdermal Patches Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Patch Type (Drug-In-Adhesive, Matrix Patches, Reservoir Membrane Patches, Microneedle Patches, Vapour Patches)
    • 5.2.2. By Adhesive Type (Acrylic, Silicone, Hydrogel, Other)
    • 5.2.3. By Application (Pain Management, Hormonal Application, Central Nervous System Disorders, Cardiovascular Diseases, Smoking Cessation, Other)
    • 5.2.4. By End-User (Homecare Settings, Hospitals & Clinics)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America Transdermal Patches Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Patch Type
    • 6.2.2. By Adhesive Type
    • 6.2.3. By Application
    • 6.2.4. By End-User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Transdermal Patches Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Patch Type
        • 6.3.1.2.2. By Adhesive Type
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End-User
    • 6.3.2. Canada Transdermal Patches Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Patch Type
        • 6.3.2.2.2. By Adhesive Type
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End-User
    • 6.3.3. Mexico Transdermal Patches Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Patch Type
        • 6.3.3.2.2. By Adhesive Type
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End-User

7. Europe Transdermal Patches Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Patch Type
    • 7.2.2. By Adhesive Type
    • 7.2.3. By Application
    • 7.2.4. By End-User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Transdermal Patches Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Patch Type
        • 7.3.1.2.2. By Adhesive Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End-User
    • 7.3.2. France Transdermal Patches Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Patch Type
        • 7.3.2.2.2. By Adhesive Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End-User
    • 7.3.3. United Kingdom Transdermal Patches Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Patch Type
        • 7.3.3.2.2. By Adhesive Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End-User
    • 7.3.4. Italy Transdermal Patches Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Patch Type
        • 7.3.4.2.2. By Adhesive Type
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End-User
    • 7.3.5. Spain Transdermal Patches Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Patch Type
        • 7.3.5.2.2. By Adhesive Type
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End-User

8. Asia Pacific Transdermal Patches Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Patch Type
    • 8.2.2. By Adhesive Type
    • 8.2.3. By Application
    • 8.2.4. By End-User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Transdermal Patches Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Patch Type
        • 8.3.1.2.2. By Adhesive Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End-User
    • 8.3.2. India Transdermal Patches Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Patch Type
        • 8.3.2.2.2. By Adhesive Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End-User
    • 8.3.3. Japan Transdermal Patches Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Patch Type
        • 8.3.3.2.2. By Adhesive Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End-User
    • 8.3.4. South Korea Transdermal Patches Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Patch Type
        • 8.3.4.2.2. By Adhesive Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End-User
    • 8.3.5. Australia Transdermal Patches Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Patch Type
        • 8.3.5.2.2. By Adhesive Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End-User

9. Middle East & Africa Transdermal Patches Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Patch Type
    • 9.2.2. By Adhesive Type
    • 9.2.3. By Application
    • 9.2.4. By End-User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Transdermal Patches Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Patch Type
        • 9.3.1.2.2. By Adhesive Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End-User
    • 9.3.2. UAE Transdermal Patches Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Patch Type
        • 9.3.2.2.2. By Adhesive Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End-User
    • 9.3.3. South Africa Transdermal Patches Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Patch Type
        • 9.3.3.2.2. By Adhesive Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End-User

10. South America Transdermal Patches Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Patch Type
    • 10.2.2. By Adhesive Type
    • 10.2.3. By Application
    • 10.2.4. By End-User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Transdermal Patches Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Patch Type
        • 10.3.1.2.2. By Adhesive Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End-User
    • 10.3.2. Colombia Transdermal Patches Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Patch Type
        • 10.3.2.2.2. By Adhesive Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End-User
    • 10.3.3. Argentina Transdermal Patches Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Patch Type
        • 10.3.3.2.2. By Adhesive Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Transdermal Patches Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. AbbVie, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. AdhexPharma SAS
  • 15.3. Agile Therapeutics, Inc.
  • 15.4. Boehringer Ingelheim International GmbH
  • 15.5. Corium, Inc.
  • 15.6. GlaxoSmithKline PLC
  • 15.7. Johnson & Johnson Services, Inc.
  • 15.8. Novartis AG
  • 15.9. Hamamatsu Pharma Research, Inc.
  • 15.10. Endo, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer